The concept of innovative drugs is repeatedly active, and Chenxin Pharmaceuticals has been limit-up for 8 consecutive days.

The concept of innovative drugs is constantly active, with Chenxin Pharmaceuticals experiencing 8 consecutive days of hitting the daily limit, Shanghai Yizhong rising by 20cm, and Nanxin Pharmaceuticals and Ruizhi Pharmaceuticals rising by more than 10%. Asia-Pacific Pharmaceuticals, Jinshi Asia Pharmaceuticals, CR Double Crane Pharmaceuticals, and Aurit are among the top gainers.